Skip to main content

Table 7 Comparison of the effects and costs of the MRTP and control at 4.7 years (Baker et al.) [26]

From: Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence

 

MRTP

Control

Difference

Number of client years

897.8

897.8

 

Program delivery cost (incremental)

$987,926

$0

$987,926

Endpoint: ESKD treatment

   

ESKD treatment years incurred

27.7

64.5

−36.8

ESKD treatment costs incurred

$3,120,350

$7,265,796

–$4,145,446

Total cost (program and ESKD costs)

$4,108,276

$7,265,796

–$3,157,521

Endpoint: dialysis start

   

Relative risk for treatment versus control

0.43 (0.19–0.96), p = 0.012

 

Reduction in risk of starting dialysis in the treatment versus control

57 %, p = 0.03

  

Number of dialysis starts

11

26

−15

Lifetime ESKF treatment costs incurred

$3,853,332

$9,107,875

–$5,254,543

Total cost (program and lifetime ESKD costs)

$4,841,258

$9,107,875

–$4,266,618